Moore Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-350,000
Closed -$27.8M 684
2025
Q4
$27.8M Buy
350,000
+25,000
+8% +$1.97M 0.4% 51
2025
Q3
$24.5M Sell
325,000
-50,000
-13% -$3.43M 0.34% 73
2025
Q2
$25.9M Buy
375,000
+235,000
+168% +$15.4M 0.32% 67
2025
Q1
$9.48M Sell
140,000
-336,569
-71% -$20.1M 0.2% 110
2024
Q4
$21.4M Buy
+476,569
New +$26.7M 0.25% 106
2022
Q1
Sell
-171,190
Closed -$17.7M 771
2021
Q4
$17.7M Sell
171,190
-129,481
-43% -$12M 0.35% 54
2021
Q3
$25.5M Buy
300,671
+69,279
+30% +$5.8M 0.39% 56
2021
Q2
$19.3M Buy
+231,392
New +$18.9M 0.27% 79
2017
Q1
Sell
-125,008
Closed -$9.86M 202
2016
Q4
$9.86M Buy
+125,008
New +$10.1M 0.32% 77
2016
Q3
Sell
-2,679
Closed -$256K 270
2016
Q2
$256K Buy
+2,679
New +$267K 0.01% 243
2015
Q4
Sell
-123,000
Closed -$11.9M 303
2015
Q3
$11.9M Buy
123,000
+73,000
+146% +$7.67M 0.55% 40
2015
Q2
$5.24M Buy
+50,000
New +$5.11M 0.11% 176
2014
Q3
Sell
-5,316
Closed -$400K 417
2014
Q2
$400K Buy
+5,316
New +$402K 0.01% 440

Other funds holding CVS

Moore Capital Management's CVS Position: Q1 2026 in Review

Moore Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 350,000 shares — an estimated $27.8M sold.

Moore Capital Management first reported a position in CVS in Q2 2014 and held it in 13 quarters. The position peaked at $27.8M in Q4 2025. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Moore Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Moore Capital Management sold 350,000 CVS Health shares in Q1 2026, an estimated $27.8M.
  • Moore Capital Management first reported a position in CVS Health in Q2 2014 and held it in 13 quarters.
  • Moore Capital Management's CVS Health position peaked at $27.8M in Q4 2025.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.